Application of an in Vitro Blood–Brain Barrier Model in the Selection of Experimental Drug Candidates for the Treatment of Huntington’s Disease-Reference-Cited by-同舟云学术

Application of an in Vitro Blood–Brain Barrier Model in the Selection of Experimental Drug Candidates for the Treatment of Huntington’s Disease

Published:2019-03-27 Issue:5 Volume:16 Page:2069-2082
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Di Marco Annalise^ORCID,Gonzalez Paz Odalys,Fini Ivan,Vignone Domenico,Cellucci Antonella,Battista Maria Rosaria,Auciello Giulio,Orsatti Laura,Zini Matteo,Monteagudo Edith,Khetarpal Vinod¹,Rose Mark¹,Dominguez Celia¹,Herbst Todd¹,Toledo-Sherman Leticia¹,Summa Vincenzo,Muñoz-Sanjuán Ignacio¹

Affiliation:

1. CHDI Management, CHDI Foundation, Center Drive Los Angeles 6080, California, United States

Funder

CHDI Foundation, Inc.

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.9b00042

Reference61 articles.

1. Huntington's disease: a clinical review